500MHz Console Upgrade

描述（由申请人提供）：在本提案中，我们要求对Varian Associates制造的Unity 500 MHz NMR光谱仪进行控制台升级。Unity 500已经过时了三代，其性能不再满足该机构内大多数NIH用户的需求。此次升级将提高现有仪器的灵敏度、分辨率和可靠性，从而实现更复杂的实验和更高的用户吞吐量。核磁共振设施，已经存在了30年，博士。一名二级专业核磁共振波谱仪操作员任主任，长期从事用户培训、仪器维护和监督工作。Unity 500 MHz仪器用户群主要由具有持续NIH支持记录的教师组成。除了主要用户之外，康奈尔大学目前还有三个次要用户，他们的群体都很年轻，他们的PI最终将依赖于NIH的支持。这些人和他们的学生将使用所要求的仪器进行广泛的健康相关项目。B教授。Ganem（PI）正在研究基于天然产物COTC的新合成前药的设计，该天然产物将专门针对前列腺组织，以及合成新的鞘糖脂代谢抑制剂; T. P. Begley教授将使用仪器研究修饰的酶底物，设计的抑制剂，产品和机械探针;克拉迪教授正在研究真菌代谢物表现出抗癌，抗病毒和抗生素活性;教授B.R.起重机旨在了解蛋白质结构如何控制生物催化和信号转导中的氧化还原和光化学。G.W.教授科茨将研究用于生物医学用途的结构明确的生物可降解聚合物的合成新方法; Collum正在使用NMR研究有机锂的溶剂化和聚集状态，以获得对合成有用的锂试剂的新见解; McQuade将使用NMR设计高度官能化聚合物的新合成方法; J. Meinwald教授将研究参与化学通讯的生物重要分子的结构。

DESCRIPTION (provided by applicant): In this proposal we request a console upgrade for a Unity 500 MHz NMR Spectrometer manufactured by Varian Associates. The Unity 500 is three generations out of date and the performance no longer meets the needs of the majority of NIH users within the facility. The upgrade will improve the sensitivity, resolution, and reliability of the current instrument allowing for more sophisticated experiments and higher user throughput. The NMR Facility, which has been in existence for 30 years with a Ph.D. level professional NMR spectroscopist as Director, has a long track record of user training, instrument maintenance, and supervision. The Unity 500 MHz instrument user base consists mostly of faculty with a record of continuous NIH support. Beyond the major users, Cornell currently has three minor users whose groups are young and whose PIs will eventually rely on NIH support. These individuals and their students will use the requested instrumentation for a wide range of health-related projects. Professor B. Ganem (PI) is studying the design of new synthetic prodrugs based on the natural product COTC, which would be targeted specifically to prostate tissue, as well as on the synthesis of new inhibitors of glycosphingolipid metabolism; Professor T.P. Begley will use the instrumentation to study modified enzyme substrates, designed inhibitors, products and mechanistic probes; Professor J. Clardy is investigating fungal metabolites exhibiting anticancer, antiviral, and antibiotic activity; Professor B.R. Crane aims to understand how protein structure controls redox- and photochemistry in biological catalysis and signal transduction. Professor G.W. Coates will investigate new methods for the synthesis of architecturally well-defined biodegradable polymers for biomedical use; Prof. D.B. Collum is investigating organolithium solvation and aggregation states using NMR to obtain new insights into synthetically useful lithium reagents; Professor D.T. McQuade will use NMR in designing new synthetic approaches to highly functionalized polymers; Prof. J. Meinwald will investigate the structures of biologically significant molecules involved in chemical communication.